Skip to main content
Log in

Cyclosporine a prevents neurological deterioration of patients with SAH — A preliminary report

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

In the present study we found that the neurological outcome in patients anaesthetised for early clipping (up to 72 h after SAH) of a ruptured aneurysm and treated with cyclosporine A was significantly better than the neurological state of control patients without immuno-suppressive treatment.

The results justify the presumption that auto-immune reactions are involved in the deterioration of the postoperative neurological state of patients with SAH after rupture of an intracranial aneurysm. Supplementing a standard surgical and pharmacological treatment with cyclosporine A seems to reduce the undesirable neurological consequences of the immunologically, induced vascular disturbance after SAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ball PE, Munzer H, Keller HP, Abisch E, Rosenthaler J (1988) Specific3H radio-immunoassay with a monoclonal antibody for monitoring ciclosporine in blood. Clin Chem 34: 257–261

    PubMed  Google Scholar 

  2. Hunt WE, Kassell N, Pertuiset B, Sano K, Teasdale G, Villier De JC, Drake CG (1988) Report of World Federation of Neurological Surgeons. Committee on a universal subarachnoid haemorrhage grading scale. J Neurosurg 68: 985–986

    PubMed  Google Scholar 

  3. Jannett B, Bond M (1975) Assessment of outcome after severe brain damage. A practical scale. Lancet 1: 480–484

    PubMed  Google Scholar 

  4. Nyberg-Hansen R, Gjerstad L (1985) Sandimmun (CYA) in the treatment of myasthenia gravis: preliminary results from a pilot study. In: Schindler R (ed) Ciclosporin in auto-immune diseases. Springer, Berlin Heidelberg New York, pp 96–99

    Google Scholar 

  5. Ohman J, Heiskanen O (1988) Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid haemorrhage and surgery. J Neurosurg 69: 683–686

    PubMed  Google Scholar 

  6. Ostergaard JR, Kristensen BO, Svehag SE, Teisner B, Miletic T (1987) Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg 66: 891–897

    PubMed  Google Scholar 

  7. Pellettieri L, Carlsson CA, Lindholm L (1981) Is the vasospasm following subarachnoid haemorrhage an immunoreactive disease? Experientia 37: 1170–1171

    PubMed  Google Scholar 

  8. Pellettieri L, Nilsson B, Carlson CA, Nilsson U (1986) Serum immunocomplexes in patients with subarachnoid haemorrhage. Neurosurgery 19: 767–771

    PubMed  Google Scholar 

  9. Peterson IW, Nishizawa S, Hackett ID, Bun T, Teramura A, Zervas NT (1990) Cyclosporine A reduces cerebral vasospasm after subarachnoid haemorrhage in dogs. Stroke 21: 133–137

    PubMed  Google Scholar 

  10. Sano K, Saito I (1978) Timing and indication of surgery for ruptured of intracranial aneurysms with regard to cerebral vasospasm. Acta Neurochir (Wien) 41: 49–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was approved by the Human Investigation Committee of the Warsaw Medical School (15/11/88).

Supported by Polish Academy of Sciences. Grant No WVI/Kom/ 89.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryba, M., Pastuszko, M., Iwanska, K. et al. Cyclosporine a prevents neurological deterioration of patients with SAH — A preliminary report. Acta neurochir 112, 25–27 (1991). https://doi.org/10.1007/BF01402450

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01402450

Keywords

Navigation